Mardi Dier Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
Get free email notifications about insider trading for Mardi Dier.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mardi Dier. Mardi Dier is EVP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and EVP, CFO & CBO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Executive VP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Interim Co-President & CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Senior VP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Adamas Pharmaceuticals Inc ($ADMS) and CFO & Executive Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Oric Pharmaceuticals, Inc. ($ORIC).
Mardi Dier in Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mardi Dier: CFO & Executive Vice President
Holdings: 45,500 shares
Current Value: $3,317,405
Latest Transaction: Mar 03 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mardi Dier in Ultragenyx Pharmaceutical Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMS, ORIC, PTLA, PRLD, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Grant | A | 0.00 | 5,500 | 0 | 45,500 | 40 K to 45.5 K (+13.75 %) |
| Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Option Exercise | A | 95.50 | 40,000 | 3,820,000 | 40,000 | |
| Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Page: 1